Birdwatch Note Rating
2023-03-15 21:08:38 UTC - NOT_HELPFUL
Rated by Participant: D77736276B7C6BD6F395962139F587EC5D490C25D2320358C21C24F2CA1152BC
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details